ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K105. A total of 15 filers reported holding ACASTI PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,000 | -96.3% | 11,235 | -93.1% | 0.00% | -100.0% |
| Q4 2014 | $82,000 | +51.9% | 163,793 | +122.4% | 0.00% | 0.0% |
| Q3 2014 | $54,000 | +86.2% | 73,653 | +165.1% | 0.00% | – |
| Q2 2014 | $29,000 | -42.0% | 27,780 | -36.9% | 0.00% | -100.0% |
| Q1 2014 | $50,000 | -5.7% | 44,043 | +97.7% | 0.00% | 0.0% |
| Q3 2013 | $53,000 | – | 22,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 4,731,200 | $1,252,000 | 0.05% |
| INTACT INVESTMENT MANAGEMENT INC. | 1,347,800 | $452,000 | 0.02% |
| Fiera Capital Corp | 621,542 | $1,554,000 | 0.01% |
| Alpine Global Management, LLC | 10,000 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 18,131 | $4,000 | 0.00% |
| Citadel Advisors | 36,095 | $10,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 447,023 | $120,000 | 0.00% |
| 1832 Asset Management L.P. | 272,812 | $69,000 | 0.00% |
| Renaissance Technologies | 64,100 | $17,000 | 0.00% |
| ROYAL BANK OF CANADA | 5,000 | $1,000 | 0.00% |